- Home
- ACDC vs COLL Comparison
ACDC vs COLL Comparison
Compare ACDC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- COLL
- Stock Information
- Founded
- ACDC 2014
- COLL 2002
- Country
- ACDC United States
- COLL United States
- Employees
- ACDC N/A
- COLL N/A
- Industry
- ACDC Oilfield Services/Equipment
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- ACDC Energy
- COLL Health Care
- Exchange
- ACDC Nasdaq
- COLL Nasdaq
- Market Cap
- ACDC 1.1B
- COLL 1.0B
- IPO Year
- ACDC 2022
- COLL 2015
- Fundamental
- Price
- ACDC $7.69
- COLL $30.72
- Analyst Decision
- ACDC Hold
- COLL Strong Buy
- Analyst Count
- ACDC 5
- COLL 5
- Target Price
- ACDC $7.40
- COLL $43.60
- AVG Volume (30 Days)
- ACDC 442.9K
- COLL 441.9K
- Earning Date
- ACDC 03-12-2025
- COLL 02-20-2025
- Dividend Yield
- ACDC N/A
- COLL N/A
- EPS Growth
- ACDC N/A
- COLL 757.11
- EPS
- ACDC N/A
- COLL 2.16
- Revenue
- ACDC $2,225,300,000.00
- COLL $599,245,000.00
- Revenue This Year
- ACDC N/A
- COLL $13.25
- Revenue Next Year
- ACDC N/A
- COLL $18.14
- P/E Ratio
- ACDC N/A
- COLL $14.24
- Revenue Growth
- ACDC N/A
- COLL 9.62
- 52 Week Low
- ACDC $5.16
- COLL $28.39
- 52 Week High
- ACDC $9.75
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- ACDC 46.77
- COLL 45.90
- Support Level
- ACDC $7.00
- COLL $32.28
- Resistance Level
- ACDC $9.40
- COLL $33.45
- Average True Range (ATR)
- ACDC 0.51
- COLL 1.07
- MACD
- ACDC -0.14
- COLL -0.16
- Stochastic Oscillator
- ACDC 28.75
- COLL 2.05
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.